articleScienceJul 26, 2013Closed access

Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4

PDL BioPharma (United States) · Innate Pharma (France) · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

Gram-negative bacteria including Escherichia coli, Citrobacter rodentium, Salmonella typhimurium, and Shigella flexneri are sensed in an ill-defined manner by an intracellular inflammasome complex that activates caspase-11. We show that macrophages loaded with synthetic lipid A, E. coli lipopolysaccharide (LPS), or S. typhimurium LPS activate caspase-11 independently of the LPS receptor Toll-like receptor 4 (TLR4). Consistent with lipid A triggering the noncanonical inflammasome, LPS containing a divergent lipid A structure antagonized caspase-11 activation in response to E. coli LPS or Gram-negative bacteria. Moreover, LPS-mutant E. coli failed to activate caspase-11. Tlr4(-/-) mice primed with TLR3 agonist…

Citation impact

1,530
total citations
FWCI
44.30
Percentile
100%
References
35
Citations per year

Authors

13

Topics & keywords

Keywords
  • TLR4
  • Inflammasome
  • Lipopolysaccharide
  • Innate immune system
  • Cytoplasm
  • Lipid A
  • Toll-like receptor
  • Intracellular
No related works found for this paper.